Structure and characterization of the first form of liguzinediol

来源 :2016年长三角药物化学研讨会 | 被引量 : 0次 | 上传用户:valerianforever
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Liguzineiol has been recently discovered as a potential agent for treatment of heart failure with low safety risk.In this manuscript,we have undertaken a systematic exploration of the liguzinediol polymorphs.
其他文献
会议
会议
会议
会议
会议
会议
Scutellarin (1) was readily hydrolyzed into scutellarein (2) in the intestine and then metabolited into methylated,sulfated or glucuronidated forms.
会议
6-O-methyl-scutellarein (Figure 1),as the main metabolite of scutellarin (Figure 1) in vivo,has not been reported about its protective effects.
Histone deacetylases (HDAC) enzyme plays a significant role in transcriptional regulation by modifying the core histones of the nucleosome,therefore it has emerged as an important therapeutic target f
The liguzinediol was a potential drug for the treatment of heart failure with high effect and low safety risk.However,in vivo pharmacokinetic study showed elimination half-life (t1/2) was too short,ac